
Cardiac Electrophysiology and Interventional Medical Device R&D Manufacturer

Minimally Invasive Cardiovascular and Cerebrovascular Interventional Device R&D, Manufacturer, and Distributor
APT Medical (688617.SH) Announces that the Company, Its Wholly-Owned Subsidiary APT Medical Inc. (Hunan), and Its Controlling Subsidiary Shanghai Hong Tong Industries Inc. Co., Ltd. Have Accumulatively Received Government Subsidies Totaling RMB 13.3315 Million from February 9, 2021, to January 5, 2022.